- Report
- February 2026
- 175 Pages
Global
From €4196EUR$4,650USD£3,636GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,511GBP
- Report
- October 2025
- 250 Pages
Global
From €4052EUR$4,490USD£3,511GBP
- Report
- August 2025
- 199 Pages
Global
From €3199EUR$3,545USD£2,772GBP
€3555EUR$3,939USD£3,080GBP
- Report
- August 2025
- 195 Pages
Global
From €3199EUR$3,545USD£2,772GBP
€3555EUR$3,939USD£3,080GBP
- Report
- January 2026
- 197 Pages
Global
From €3199EUR$3,545USD£2,772GBP
€3555EUR$3,939USD£3,080GBP
- Report
- January 2026
- 181 Pages
Global
From €3199EUR$3,545USD£2,772GBP
€3555EUR$3,939USD£3,080GBP
- Report
- August 2025
- 192 Pages
Global
From €3199EUR$3,545USD£2,772GBP
€3555EUR$3,939USD£3,080GBP
- Report
- December 2025
- 200 Pages
Global
From €2247EUR$2,490USD£1,947GBP
- Report
- June 2026
- 145 Pages
Global
From €3609EUR$3,999USD£3,127GBP
- Report
- May 2026
- 147 Pages
Global
From €3609EUR$3,999USD£3,127GBP
- Report
- April 2026
- 149 Pages
Global
From €3609EUR$3,999USD£3,127GBP
- Report
- April 2026
- 142 Pages
Global
From €3609EUR$3,999USD£3,127GBP
- Report
- April 2026
- 137 Pages
Global
From €3609EUR$3,999USD£3,127GBP
- Report
- April 2026
- 143 Pages
Global
From €3609EUR$3,999USD£3,127GBP
- Report
- March 2026
- 140 Pages
Global
From €3609EUR$3,999USD£3,127GBP
- Report
- March 2026
- 136 Pages
Global
From €3609EUR$3,999USD£3,127GBP
- Report
- July 2025
Global
From €4422EUR$4,900USD£3,832GBP
- Report
- July 2025
- 128 Pages
Global
From €4422EUR$4,900USD£3,832GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,511GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more